文献速递冠心病外科

脱细胞人内乳动脉作为新型小口径血管移植物在动物模型中的三年疗效与通畅性随访

Three-year efficacy and patency follow-up of decellularized human internal mammary artery as a novel vascular graft in animal models.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-09-28

研究将脱细胞人内乳动脉支架植入8只新西兰兔股浅动脉,随访36个月。所有动物存活,CT血管造影证实移植物通畅,组织学显示支架三层均再细胞化,中膜检出平滑肌细胞,提示脱细胞人内乳动脉可作为高效的小口径血管替代物。

要点

  • 脱细胞人内乳动脉支架在兔股浅动脉端端吻合后36个月保持通畅。
  • 组织学证实支架三层再细胞化,中膜存在平滑肌细胞。
  • 脱细胞处理有效去细胞并保留细胞外基质。

核心结论

  • 脱细胞人内乳动脉可作为高效的小口径血管替代物,具有高通畅性。

研究设计与样本

  • 动物实验:将脱细胞人内乳动脉支架端端吻合植入8只新西兰兔股浅动脉。
  • 术后3、12、36个月行CT血管造影,随后处死动物取活检行组织学与免疫组化评估。

主要发现

  • 脱细胞组织评估证实去细胞方案有效且细胞外基质保留。
  • 8只动物全部存活至整个随访期。
  • 多普勒超声与CT血管造影证实移植物通畅。
  • 组织学显示支架三层均再细胞化,中膜检出平滑肌细胞,免疫组化证实上述发现。

临床怎么用

  • 为小口径血管旁路(包括冠状动脉旁路移植)提供潜在新型移植物选择,尚需进一步临床研究验证。

局限性

  • 仅动物模型(8只新西兰兔),样本量小,尚未在人体验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Various investigations have reported that the internal mammary artery (IMA) is an efficient and functional choice of conduit for vascular graft surgeries, especially for coronary artery bypass grafts; however, the quest to find an ideal vascular substitute remains. We hypothesized that acellular IMA could be an appropriate graft for small-diameter vascular bypasses that could be used in various surgeries including coronary artery bypass grafting. METHODS: We decellularized human IMAs and performed histologic evaluations and scanning electron microscopy to confirm the decellularization process and the preservation of the extracellular matrix. Subsequently, we grafted the scaffolds into the superficial femoral arteries of 8 New Zealand rabbits with an end-to-end anastomosis. Computed tomography angiograms were provided at 3, 12, and 36 months postoperatively. Subsequently, the animals were killed, and biopsies were taken for histologic and immunohistochemical assessments. RESULTS: Evaluation of the acellular tissue confirmed the efficacy of the decellularization protocol and the preservation of the extracellular matrix. All 8 animals survived the entire follow-up period. Doppler ultrasonography and computed tomography angiographies verified the conduit's patency. Histologic assessments depicted the recellularization of all 3 layers of the scaffold. Smooth muscle cells were detected in tunica media. Immunohistochemical assessments confirmed these findings. CONCLUSIONS: In conclusion, we demonstrated that acellular human IMA could be used as an efficient small-diameter vascular substitute with high patency. These findings could pave the path for future investigations on the clinical application of acellular IMA as a novel vascular graft for small-diameter bypass surgeries.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Kajbafzadeh AM, Khorramirouz R, Kameli SM, et al. Three-year efficacy and patency follow-up of decellularized human internal mammary artery as a novel vascular graft in animal models. J Thorac Cardiovasc Surg. 2018. PMID: 30396737. doi:10.1016/j.jtcvs.2018.08.106

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。